Associations Between Short-Term Changes in Disease Activity and…
Leniolisib treatment quickly improved immune function in APDS patients, and these early improvements predicted better long-term outcomes including fewer infections.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Implementing multimodal liquid biopsy in glioblastoma
Researchers developed a reproducible workflow for detecting cancer markers in blood, laying groundwork for larger studies on this less invasive approach.
Underserved or high-risk populationsDiagnosis Through Whole Genome Sequencing and Care Utilization in…
Genetic testing identified serious conditions in critically ill children, helping clinicians better plan and manage their complex ongoing care needs.
Novel or significantly improved treatmentPre-existing immunity and hrHPV status determine immunotherapy…
Certain immune cell markers in penile cancer predict which patients benefit most from immunotherapy, potentially guiding personalized treatment choices.
Standard additionThe next-generation biomarkers in early-stage triple negative breast cancer.
Combining multiple genetic tests shows promise for tailoring breast cancer treatment to each patient while balancing benefit against side effects.